The Clinical Study of Rituximab Combined With Mesenchymal Stem Cells in the Treatment of Primary Nephrotic Syndrome (3-4 Stage of Chronic Kidney Disease)

Trial Profile

The Clinical Study of Rituximab Combined With Mesenchymal Stem Cells in the Treatment of Primary Nephrotic Syndrome (3-4 Stage of Chronic Kidney Disease)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs Mesenchymal stem cell therapy (Primary) ; Rituximab (Primary)
  • Indications Nephrotic syndrome; Renal failure
  • Focus Therapeutic Use
  • Acronyms CKD
  • Most Recent Events

    • 21 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top